News & Updates

Continued treatment with tumor necrosis factor (TNF) inhibitors after 24 weeks of pregnancy appears safe and is associated with lower chances of maternal inflammatory bowel disease (IBD) relapse, without increasing adverse neonatal outcomes, new research suggests.

In Japan, the prevalence of hypertrophic cardiomyopathy (HCM), regardless of subtype, increased between 2016 and 2020, a recent study has found.

Using a lower glycaemic threshold led to more diagnoses of gestational diabetes, though its impact on maternal and birth outcomes remains uncertain, results of the GEMS* trial showed.

Oral gonadotropin-releasing hormone (GnRH) antagonists help relieve pain in women with endometriosis or dysmenorrhea, according to the results of a meta-analysis.

Researchers have recently developed and validated an 8-item score to calculate the risk of cardiovascular (CV) death and myocardial infarction (MI) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention.